Turkish Journal of Medical Sciences
Volume 44

Number 3

Article 3

1-1-2014

Neutrophil-lymphocyte ratio as a predictive factor for tumor
staging in colorectal cancer
GÜLAY ÖZGEHAN
ŞAHİN KAHRAMANCA
İSMAİL OSKAY KAYA
KÖKSAL BİLGEN
HASAN BOSTANCI

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ÖZGEHAN, GÜLAY; KAHRAMANCA, ŞAHİN; KAYA, İSMAİL OSKAY; BİLGEN, KÖKSAL; BOSTANCI, HASAN;
GÜZEL, HAKAN; KÜÇÜKPINAR, TEVFİK HADİ; and KARGICI, HÜLAGÜ (2014) "Neutrophil-lymphocyte ratio
as a predictive factor for tumor staging in colorectal cancer," Turkish Journal of Medical Sciences: Vol. 44:
No. 3, Article 3. https://doi.org/10.3906/sag-1305-33
Available at: https://journals.tubitak.gov.tr/medical/vol44/iss3/3

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal
cancer
Authors
GÜLAY ÖZGEHAN, ŞAHİN KAHRAMANCA, İSMAİL OSKAY KAYA, KÖKSAL BİLGEN, HASAN BOSTANCI,
HAKAN GÜZEL, TEVFİK HADİ KÜÇÜKPINAR, and HÜLAGÜ KARGICI

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol44/iss3/3

Turkish Journal of Medical Sciences

Turk J Med Sci
(2014) 44: 365-368
© TÜBİTAK
doi:10.3906/sag-1305-33

http://journals.tubitak.gov.tr/medical/

Research Article

Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer
1

1,

1

2

Gülay ÖZGEHAN , Şahin KAHRAMANCA *, İsmail Oskay KAYA , Köksal BİLGEN ,
1
1
1
1
Hasan BOSTANCI , Hakan GÜZEL , Tevfik KÜÇÜKPINAR , Hülagü KARGICI
1
General Surgery Clinic, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Altındağ, Ankara, Turkey
2
Department of General Surgery, Faculty of Medicine, Ordu University, Ordu, Turkey
Received: 06.05.2013

Accepted: 06.08.2013

Published Online: 31.03.2014

Printed: 30.04.2014

Background/aim: In the preoperative period, simple methods to identify the tumor stage of colorectal cancer patients are needed. In
recent years, the neutrophil-lymphocyte ratio (NLR) has been used as a predictive parameter for systemic inflammatory response in
many different clinical entities. This study aims to determine if the NLR predicts the tumor stage in colorectal cancer patients in the
preoperative period.
Materials and methods: A total of 206 patients diagnosed with colorectal cancer and admitted for surgical treatment over a 6-year
period were identified from a retrospectively maintained database. NLR was calculated from preoperative full blood counts. NLRs were
compared with the tumor stages as determined in histopathological reports and scanning tests to determine the extent of metastasis.
Results: We found NLRs to be statistically higher in patients with T3 and T4 tumors than in patients with T1 and T2 tumors (mean:
5.261 vs. 4.499, respectively, P = 0.010). Similarly, we found statistically higher NLR values in the N1 and N2 groups than in the N0
group (mean: 6.597 vs. 4.501, respectively, P < 0.001). Additionally, NLRs were statistically higher in M1 patients than in M0 patients
(mean: 8.261 vs. 5.158, respectively, P = 0.004).
Conclusion: In the preoperative period, NLR was found to be a valuable predictive parameter for tumor staging in patients with
colorectal cancer, thus informing us as to the kind of tumor we will meet when we open the abdomen.
Key words: Systemic inflammatory response syndrome, colorectal neoplasms, neoplasm staging

1. Introduction
The response of the body to a cancer has many parallels
to inflammation. German pathologist Rudolf Virchow
first found inflammatory cells in tumors 150 years ago (1).
Lately the human inflammatory response to tumors has
been more frequently investigated (2). Higher neutrophillymphocyte ratios (NLRs) have been accepted as a poor
prognostic criterion in various cancer patients (3). In the
present study we investigated the potential association
between the preoperative NLR and the colorectal cancer
(CRC) stage. In the preoperative preparation period, many
laboratory and radiological test possibilities exist. First, any
surgeon wants to know the invasion degree of the tumor
before the operation without doubt. Thus, surgical planning
would be more relevant. NLR is an inexpensive, simple, and
noninvasive test, and it may be helpful for this purpose.
2. Materials and methods
After approval from the local ethics committee, we
examined 288 patients who were diagnosed with CRC and
* Correspondence: drkahramancasahin@gmail.com

received for surgical treatment from January 2006 to January
2011. Peripheral white blood counts and percentages
of neutrophils and lymphocytes before surgery were
obtained from the database retrospectively, and the ratio
of neutrophils to lymphocytes was directly calculated from
the full blood count. Exclusion criteria included infectious
signs determined at 1 week before admittance to the
hospital, the presence of coronary artery or cerebrovascular
disease, known additional malignancies, the presence of
hematological problems or immunosuppressant conditions,
a blood transfusion 1 month prior, and urgent conditions
due to tumor occlusion. A total of 82 patients were excluded
from the study. Hospital records of the remaining 206
patients were analyzed. Age, sex, family history, tumor
localization, intraoperative findings and surgical procedure,
preoperative NLR, and postoperative histopathology
reports were assessed prior to enrollment.
2.1. Statistical analysis
Data analysis was performed using SPSS 17 for Windows.
The Levene test was used for the evaluation of homogeneity
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of variances. Data were shown as mean ± standard
deviation or median (min–max) where applicable. The
differences between groups were compared by using the
Student t-test or Mann–Whitney U test where appropriate.
Categorical data were analyzed by the Pearson chi-square
test where appropriate. A P-value of less than 0.05 was
considered statistically significant.
The cutoff values of parameters for discrimination
of the groups were determined using receiver operating
characteristic (ROC) analysis. At each value, the sensitivity
and specificity for each outcome under study were plotted,
thus generating an ROC curve. The recommended cutoff
value of the NLR for lower or higher stages of CRC was
decided using ROC curve analyses. For T1–2/T3–4
analysis, the recommended cutoff value of the NLR was
based on the most prominent point on the ROC curve
for sensitivity (66.20%) and specificity (52.9%). Because
these 2 parameters indicated a cutoff value of 2.38, the
recommended NLR cutoff value was defined as 2.38 The
area under the ROC curve was 0.275 (95% CI: 0.184–0.367,
P < 0.001). For N0/N1–2 analysis, the recommended cutoff
value of the NLR was based on the most prominent point
on the ROC curve for sensitivity (66%) and specificity
(66%). Because these 2 parameters indicated a cutoff value
of 3.24, the recommended NLR cutoff value was defined
as 3.24. The area under the ROC curve was 0.327 (95% CI:
0.252–0.402, P < 0.001).
3. Results
A total of 206 patients were included the study. The mean
age was 60.9 years (range: 24–88), and there were 79
(38.3%) women and 127 men (61.7%). Family histories
were positive in 11 (5.3%) of these patients. The most
common localization site was the right colon (47 patients,
22.8%). There were synchronic localizations and multiple
tumors in 7 (3.4%) patients (Table 1). Twenty patients
died postoperatively within 6 months. TNM staging of the
Table 1. Tumor localizations of the patients with colorectal
cancer.

patients according to the American Joint Committee of
Cancer Staging System is given in Table 2.
In terms of tumor invasion depth, we found NLRs
statistically higher in patients with T3 and T4 tumors
than in patients with T1 and T2 tumors (mean: 5.261 vs.
4.499, respectively, P = 0.010). When we examined NLRs
according to the lymph node involvement, we found
statistically higher values in the N1 and N2 groups than
in the N0 group (mean: 6.597 vs. 4.501, respectively, P
< 0.001). However, there was no statistically important
difference between the N1 and N2 groups. From the view
of distant organ metastasis, NLRs were statistically higher
in M1 patients than M0 patients (mean: 8.261 vs. 5.158,
respectively, P = 0.004) (Table 3).
4. Discussion
Recently, the association of inflammation and cancer,
and the effects of this association in prognosis, have been
more thoroughly investigated. Balkwill and Mantovani
(1) made an analogy of genetic damage and inflammation
as the “match that lights the fire” and the “fuel that feeds
the flames”. White blood cell counts and albumin and
C-reactive protein levels are widely available information
in many healthcare systems, but they display nonspecific
changes following different clinic tables. Tilki et al. (4)
investigated plasma-soluble thrombomodulin and soluble
endothelial protein C receptor levels in patients with
different CRC stages. They found no statistical differences
between the patient groups, but they concluded that
these proteins can play an important role in tumor
development. In recent years the NLR has been found
Table 2. Cancer staging of the patients according to TNM system
[American Joint Committee on Cancer (AJCC), 7th edition].
TNM staging
(according to AJCC
7th edition)

Number of
patients (n)

Percent in the
study group (%)

Carcinoma in situ

1

0.5

Localization

n

%

I

34

16.5

Right colon

47

22.8

IIA

61

29.6

Transverse colon

5

2.4

IIB

4

1.9

Left colon-sigmoid colon

40

19.4

IIIA

7

3.4

Rectum

104

50.5

IIIB

41

19.9

Anal canal

3

1.5

IIIC

30

14.6

Synchronic multiple

7

3.4

IV

28

13.6

Total

206

100

Total

206

100
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Table 3. Comparing the NLRs between patient groups with different cancer stages.

Colorectal cancer
patients

NLR
Mean

Std.
dev.

Min.

Max.

Med.

T1–T2

4.499

5.562

0.66

37.5

2.86

T3–T4

5.261

6.430

0.24

16.0

2.26

Lymph node
invasion

N0

4.501

5.534

0.24

37.5

2.57

N1–N2

6.597

7.672

0.33

48.2

4.05

Distant organ
metastasis

M0

5.158

6.09

0.24

43.0

3.14

M1

8.261

9.891

0.33

48.2

4.30

Tumor depth

P-value

Cutoff
Value

Sens.

Spec.

PPV

NPV

0.010

2.38

66.2%

52.9%

72.9%

45.0%

<0.001

3.24

66.0%

66.0%

67.3%

64.7%

0.004

3.48

64.3%

38.8%

14.2%

87.3%

NLR: Neutrophil-lymphocyte ratio, Std. dev.: standard deviation, Min.: minimum, Max.: maximum, Sens.: sensitivity, Spec.: specificity,
PPV: positive predictive value, NPV: negative predictive value.

as a simple index of inflammatory response. Sayan et
al. (5) used NLR combined with interleukin and tumor
makers and found these data valuable in the diagnosis
of endometriosis. Tumor development and growth occur
as a result of interactions among the tumor, host-derived
stromal tissues including blood vessels, and host immune/
inflammatory cells, with chronic inflammation having an
important role in cancer development and progression (6).
There are several possible explanations for the association
between elevated NLR and poor oncologic outcome. As
mentioned by Ding et al. (7), the host’s immune response to
a tumor is lymphocyte-dependent. First, elevated tumorinfiltrating lymphocytes in the primary tumor have been
a well-recognized predictor of a good prognosis. Second,
elevated neutrophils may result in an increase of potent
proangiogenic factors that act directly on the nearby
vasculature to promote development and progression
of the neoplasm. Therefore, NLR can be considered as
the balance between protumor inflammatory status and
antitumor immune status.
CRC is the third leading cause of worldwide cancer
mortality and is responsible for 1.1% of total deaths (6).
We found a high mortality rate when the NLR was high in
the postoperative 6-month period (P = 0.047). Walsh et al.
(8) showed that a preoperative NLR of greater than 5 was
linked to overall and cancer-specific survival in a 2-year
prospective study of 200 patients. In different studies,
preoperative NLR of greater than 4 or 5 was found to be a
prognostic factor for recurrent CRC (7,9).
In the present study, we have investigated preoperative
NLRs in patients with CRC and association with tumor
stages according to the seventh edition of the American
Joint Committee on Cancer TNM Staging System. We

obtained records retrospectively from the database. We
found that when NLRs were elevated, there was increased
tumor invasion depth (T), lymph node involvement
(N), and distant organ metastasis (M). NLR values were
statistically higher in CRC patients with T3–T4 invasion
depth than patients with T1–T2 tumors. In patients with
N1–N2 lymph node invasion, NLR values were higher
than in the patients without lymph node invasion. Similar
high values were found when we compared the patients
with distant organ metastasis and patients without distant
metastasis (Table 3). Patients with CRC in advanced
stages were investigated for chemotherapy outcomes and
survival. NLR > 5 values were found to be predictive (6,10).
Cook et al. (11) found that postoperative NLR predicted
complications following colorectal surgery. In that study,
NLR > 9.3 on the first postoperative day correlated with
an increased risk of complications. Despite the fact that
in the study of Rashid et al. (12), it was not found to be
a predictive survival parameter for esophageal cancer
resection, NLR was a valuable predictive prognostic
parameter in other cancer types (3,13,14).
In conclusion, t NLR is a valuable marker for systemic
inflammatory response. In this study it was found to be
a preoperative predictive parameter for the tumor stage
in patients with CRC. Certainly, many opportunities are
available to diagnose tumor stage in the preoperative
period; however, the majority of them are very expensive.
NLR calculation is an inexpensive and simple test that is
always at hand. Thus, it may be useful to give an idea to
the surgeon as to the kind of tumor he or she will confront
when the abdomen is opened. Finding high NLR values
provides estimation about the high invasion degree of a
tumor or advanced N stage or metastasis.
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